SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA lifts import alert from Dr Reddys' Chemical Manufacturing Facility at Mexico

30 Jul 2012 Evaluate

Dr Reddy’s Laboratories - wholly owned subsidiary - Quimicas Falcon de Mexico SA de C.V., the company’s manufacturing facility located at Cuernavaca in Mexico’s import alert has been lifted. Dr. Reddy’s has received a clearance from the United States Food and Drug Administration (USFDA) on July 26, 2012.

The company’s Mexico facility was inspected by USFDA in November 2010. Based on observations by the USFDA, a Warning Letter was shared on June 14, 2011 with the company. The company worked with USFDA to resolve the observations in the Warning Letter.

Further, an inspection report after the last inspection from March26 - 30, 2012 indicated that USFDA are satisfied with all the outstanding action points that the company has submitted.

With the satisfactory closure of observations in the warning Letter and the lifting of the import alert, Dr. Reddy’s can now start importing products to the US from this facility. The Mexico facility produces Intermediates and Active Pharmaceutical Ingredients.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs. 

Dr. Reddys Labs. Share Price

1350.00 21.65 (1.63%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: